Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pharmacokinetic drug interactions.

M Eichelbaum

    Journal of Clinical Pharmacology
    |July 1, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Stable isotope-labeled drugs precisely reveal drug interaction mechanisms in clinical settings. This method enhances pharmacokinetic studies during steady-state, simplifying patient management.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Tamoxifen metabolism predicts drug concentrations and outcome in premenopausal patients with early breast cancer.

    The pharmacogenomics journal·2014
    Same author

    CYP2D6 genotype and adjuvant tamoxifen: meta-analysis of heterogeneous study populations.

    Clinical pharmacology and therapeutics·2013
    Same author

    [Pharmacogenetics: current state after 30 years of research].

    Deutsche medizinische Wochenschrift (1946)·2013
    Same author

    Activity levels of tamoxifen metabolites at the estrogen receptor and the impact of genetic polymorphisms of phase I and II enzymes on their concentration levels in plasma.

    Clinical pharmacology and therapeutics·2011
    Same author

    X-ray-assisted formation of gold nanoparticles in soda lime silicate glass: suppressed Ostwald ripening.

    Physical review letters·2011
    Same author

    The impact of thyroid disease on the regulation, expression, and function of ABCB1 (MDR1/P glycoprotein) and consequences for the disposition of digoxin.

    Clinical pharmacology and therapeutics·2010
    Same journal

    Population Pharmacokinetic Modeling and Simulation to Support the Regulatory Submission of the Two-Injection Start Regimen with Aripiprazole Once-Monthly Long-Acting Injectable Intramuscular Administration in Japanese Patients with Schizophrenia or Bipolar I Disorder.

    Journal of clinical pharmacology·2026
    Same journal

    External Evaluation of Population Pharmacokinetic Models for Factor VIII in Chinese Patients with Hemophilia A.

    Journal of clinical pharmacology·2026
    Same journal

    How to Replace the TQT Study-The Use of Concentration-QTc Modeling to Exclude a Small Effect of a Novel Drug on QT Interval: Historical Perspective and Implementation.

    Journal of clinical pharmacology·2026
    Same journal

    Genome Sequencing Enhances Precision and Clinical Utility of Pharmacogenetic Data Compared to Arrays.

    Journal of clinical pharmacology·2026
    Same journal

    FDA Gene Therapy Approvals (1998-2025): Current Status, Regulatory Evolution, and Future Directions.

    Journal of clinical pharmacology·2026
    Same journal

    Human Disposition, Metabolism, and Excretion of Sevasemten (EDG-5506), a Selective Modulator of Fast Myosin in Healthy Volunteers.

    Journal of clinical pharmacology·2026
    See all related articles

    Area of Science:

    • Pharmacokinetics
    • Drug Metabolism
    • Clinical Pharmacology

    Background:

    • Stable isotope-labeled drugs are valuable tools in pharmacokinetic research.
    • Understanding drug interactions is crucial for patient safety and effective treatment.
    • Traditional methods can pose challenges in patient management during drug withdrawal.

    Purpose of the Study:

    • To highlight the utility of stable isotope-labeled drugs in pharmacokinetic drug interaction studies.
    • To emphasize the precision offered by this technique in elucidating interaction mechanisms.
    • To showcase the advantages of conducting these studies under steady-state clinical conditions.

    Main Methods:

    • Utilizing drugs labeled with stable isotopes.
    • Conducting pharmacokinetic studies in a clinical setting.

    Related Experiment Videos

  • Monitoring drug metabolism, bioavailability, and volume of distribution.

    • Main Results:

    • Stable isotopes provide precise data on drug interaction mechanisms.
    • This technique accurately identifies changes in clearance due to metabolic enzyme induction or inhibition.
    • The method allows for detailed pharmacokinetic analysis during steady-state drug administration.

    Conclusions:

    • Stable isotope-labeled drugs offer a robust method for studying drug interactions.
    • The technique simplifies clinical study designs and patient management.
    • This approach yields critical insights into drug disposition and interaction pathways.